EmilyKathleenCurranMD

Oncology • Cincinnati, OH

Hematologic Oncology

Physician

Join to view full profile

Dr. Curran is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Curran's full profile

Already have an account?

Office
3130 Highland Ave
Cincinnati, OH 45219
Phone+1 513-584-4268

Fax+1 513-584-6955

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 2012 - 2015
University of ChicagoResidency, Internal Medicine, 2008 - 2011
Stanford University School of MedicineClass of 2008

Certifications & Licensure

OH State Medical License 2019 - 2025
IL State Medical License 2011 - 2020
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leuke...
Talha Badar, Ravi Narra, Alice S Mims, Michael G Heckman, Rory M Shallis
American Journal of Hematology. 2024-12-01
A Systematic Approach to Optimize the Implementation of Precision Oncology in Clinical Practice: A Meeting Proceeding.
Abdul Rahman Jazieh, Nihal El Rouby, Andrew Guinigundo, Karen M Huelsman, Emily Curran
Journal of Immunotherapy and Precision Oncology. 2024-08-01
Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia.
Ola A Elgamal, Sydney Fobare, Sandip Vibhute, Abeera Mehmood, Dennis C Vroom
JCI Insight. 2024-04-22

Abstracts/Posters

Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab Ozogamicin
Emily K Curran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
Emily K Curran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Ponatinib and Blinatumomab Combination Safe and Effective in Patients with Newly Diagnosed, Ph-Positive ALLFebruary 3rd, 2023